We demonstrated that MSC SLP inhibited the IL-6–p-STAT3 signaling pathway and then activated p63–JAG2 signaling to promote epithelial cell proliferation, inhibit cell apoptosis, reduce inflammatory cell recruitment, and ameliorate ALI. The gene discussed is STAT3; the disease is acute respiratory distress syndrome.